Janus Henderson Group
RGNX icon

Janus Henderson Group’s Regenxbio RGNX Stock Holding History

Janus Henderson Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,761
Closed -$191K – 2540
2024
Q4 		$191K Hold
24,761
– – ﹤0.01% 2442
2024
Q3 		$259K Hold
24,761
– – ﹤0.01% 2339
2024
Q2 		$290K Sell
24,761
-206
-0.8% -$3.21K ﹤0.01% 2230
2024
Q1 		$525K Buy
24,967
+1
+0% +$18 ﹤0.01% 1983
2023
Q4 		$448K Sell
24,966
-32
-0.1% -$564 ﹤0.01% 2041
2023
Q3 		$412K Buy
24,998
+6
+0% +$109 ﹤0.01% 2028
2023
Q2 		$499K Sell
24,992
-26
-0.1% -$501 ﹤0.01% 1981
2023
Q1 		$473K Buy
+25,018
New +$554K ﹤0.01% 2049
2022
Q2 		– Sell
-6,482
Closed -$215K – 2668
2022
Q1 		$215K Buy
6,482
+3
+0% +$83 ﹤0.01% 2404
2021
Q4 		$212K Buy
+6,479
New +$221K ﹤0.01% 2363
2019
Q4 		– Sell
-11,236
Closed -$400K – 1450
2019
Q3 		$400K Buy
+11,236
New +$455K ﹤0.01% 1306

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Janus Henderson Group's RGNX Position: Q1 2025 in Review

Janus Henderson Group sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 24,761 shares — an estimated $191K sold.

Janus Henderson Group first reported a position in RGNX in Q3 2019 and held it in 11 quarters. The position peaked at $525K in Q1 2024. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

  • Janus Henderson Group reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
  • Janus Henderson Group sold 24,761 Regenxbio shares in Q1 2025, an estimated $191K.
  • Janus Henderson Group first reported a position in Regenxbio in Q3 2019 and held it in 11 quarters.
  • Janus Henderson Group's Regenxbio position peaked at $525K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Janus Henderson Group's 13F filing for Q1 2025, filed 15 May 2025.